Karin Worm is a highly experienced medicinal chemist with a robust background in drug development, currently serving as the Scientific Director of Medicinal Chemistry at Novo Nordisk since November 2024. Prior experience includes roles at Bristol Myers Squibb from December 2019 to October 2024, where Karin held titles such as Scientific Associate Director, Senior Principal Scientist, and Principal Scientist, and at Celgene as a Principal Scientist from January 2011 to November 2019. Earlier positions involved significant contributions at Adolor Corporation as Principal Research Investigator and BASF as Senior Research Chemist, focusing on the design and development of innovative compounds for pain management and related areas. Educational qualifications include a PhD in Organic Chemistry from the Technical University of Munich.
This person is not in any teams
This person is not in any offices